Marion Dorsch, Founder of Atavistik Bio

Marion Dorsch is the founder of Atavistik Bio. Atavistik Bio has raised $180M in total funding. Latest round: Series A. Based in Cambridge, USA.

About Marion Dorsch

Marion Dorsch is the Co-founder and CEO of Atavistik Bio, a pre-clinical biotechnology company based in Cambridge, Massachusetts. She leads the company's efforts to develop first-in-class drug candidates powered by distinct allosteric control mechanisms. Dorsch founded Atavistik Bio in 2021 to advance genetically-validated targets in metabolic diseases and cancer.

Marion Dorsch at a glance

More founders in Cambridge, USA (44)

Browse related founder lists (5)

Full founder directory · Investor directory · Company funding database · Fundraising library